News
November 20, 2018
SWE-Life for EIC pilot grant
Medvasc AB has been granted funding from SWE-Life 100.000 SEK for the project “Solutio-Improved varicose vein surgery via new medical device “in the framework of the EIC pilot grant preparation Horizon2020, SME instruments phase 2 Read more about the grant: https://swelife.se/projekt/stod-for-att-soka-eic-pilot/…
September 3, 2018
Successful animal studies
During the past months Medvasc has conducted a successful studies on living sheep and pigs in Haifa, Israel. The Studies was conducted in a controlled manner in an operating environment and intended to investigate Solutios usability and function, both of which could be met….
November 14, 2017
MedTech4Health grant
Medvasc AB has been granted funding 2M SEK supporting the project “Solutio-Improved varicose vein surgery via new medical device Instrument” within the framework of MedTech4Health medical device twinning 2017. The funding spans two years. Read more: https://medtech4health.se/tag/medvasc/ Read more: https://www.vinnova.se/p/solutio-forbattrad-aderbrackskirurgi-via-nytt-medicintekniskt-instrument/…
September 6, 2017
Nordic Life Science Days 12-14 September
Nordic Life Science Days is the largest Nordic partnering conference dedicated to the life science industry. Since its inception in 2013, the event has nurtured a community of people from the world of life science, and created a unique place to do business. Most attendees express their delight in…
August 15, 2017
LU Holding investerar i åderbråcksbehandling
I bolaget MedVasc har Lundaforskaren Michael Åkesson placerat rättigheterna till ett medicintekniskt instrument som ska göra laserbehandling av åderbråck mindre smärtsam. Nu går affärsutvecklaren Jörgen Gustafsson in som vd och delägare tillsammans med universitetets såddfinansieringsbolag LU Holding. Michael Åkessons instrument är ett komplement till laserfiber som redan används för…
For press inquiries, please send an email
Subscribe to our newsletter
For more information on how we process your personal data please see our Privacy Notice